Dergi makalesi Açık Erişim

Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19

Kalkanli Tas, Sevgi; Uzunoglu, Merve Saide; Uzunoglu, Aylin Seher; Kirkik, Duygu; Altunkanat, Derya; Kalkanli, Nevin


JSON

{
  "conceptrecid": "256004", 
  "created": "2023-07-29T05:37:46.406029+00:00", 
  "doi": "10.55730/1300-0152.2579", 
  "files": [
    {
      "bucket": "b6138ca9-fc71-4fc4-8325-b09cf3386d8d", 
      "checksum": "md5:cf486be9c11cc4da710884d0728ade80", 
      "key": "bib-3c839f1e-b023-480d-81e7-e3d18071e6b4.txt", 
      "links": {
        "self": "https://aperta.ulakbim.gov.tr/api/files/b6138ca9-fc71-4fc4-8325-b09cf3386d8d/bib-3c839f1e-b023-480d-81e7-e3d18071e6b4.txt"
      }, 
      "size": 229, 
      "type": "txt"
    }
  ], 
  "id": 256005, 
  "links": {
    "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.55730/1300-0152.2579.svg", 
    "bucket": "https://aperta.ulakbim.gov.tr/api/files/b6138ca9-fc71-4fc4-8325-b09cf3386d8d", 
    "doi": "https://doi.org/10.55730/1300-0152.2579", 
    "html": "https://aperta.ulakbim.gov.tr/record/256005", 
    "latest": "https://aperta.ulakbim.gov.tr/api/records/256005", 
    "latest_html": "https://aperta.ulakbim.gov.tr/record/256005"
  }, 
  "metadata": {
    "access_right": "open", 
    "access_right_category": "success", 
    "communities": [
      {
        "id": "tubitak-destekli-proje-yayinlari"
      }
    ], 
    "creators": [
      {
        "affiliation": "Univ Hlth Sci, Hamidiye Med Fac, Dept Immunol, Istanbul, Turkey", 
        "name": "Kalkanli Tas, Sevgi"
      }, 
      {
        "affiliation": "Univ Hlth Sci, Hamidiye Inst Hlth Sci, Dept Immunol, Istanbul, Turkey", 
        "name": "Uzunoglu, Merve Saide"
      }, 
      {
        "affiliation": "Univ Hlth Sci, Hamidiye Inst Hlth Sci, Dept Immunol, Istanbul, Turkey", 
        "name": "Uzunoglu, Aylin Seher"
      }, 
      {
        "affiliation": "Univ Hlth Sci, Hamidiye Med Fac, Dept Med Biol, Istanbul, Turkey", 
        "name": "Kirkik, Duygu"
      }, 
      {
        "affiliation": "Univ Hlth Sci, Hamidiye Med Fac, Dept Med Biol, Istanbul, Turkey", 
        "name": "Altunkanat, Derya"
      }, 
      {
        "affiliation": "Diyarlife Hosp, Dept Dermatol, Diyarbakir, Turkey", 
        "name": "Kalkanli, Nevin"
      }
    ], 
    "description": "Coronavirus disease 2019 (COVID-19) pandemic has been an important global interest that affected millions of people, and it requires a deep investigation of the disease immunology for developing further therapeutic applications. Adoptive T cell therapy promises to address T cell-dependent immune dysregulation in COVID-19 patients by the generation of specific T cell clones against virus-specific antigens. Additionally, targeting B cell-dependent protection through COVID-19 vaccines, which have been developed in the recent year, possessed sufficient prevention for spreading the virus, since the cases and deaths related to COVID-19 tend to decrease after the vaccination. However, adoptive cell therapies are now encouraging scientists to deal with pathological challenges like inadequate T cell-dependent immune response or lymphopenia, since they are the most frequent outcome of severe infection, especially in immunocompromized patients. In this review, the current knowledge of immunopathology of COVID-19 was aimed to be highlighted along with the T cell responses against SARS-CoV-2 to comprise a basis for therapeutics. Moreover, current therapeutics and treatment strategies for COVID-19 were discussed to evaluate possible agents. Furthermore, the use of adoptive T cell therapy representing an emerging therapeutic approach was purposed to be presented comprehensively against SARS-CoV-2 infection. Even though further studies are needed to fully understand T cell response against SARS-CoV-2 in order to develop therapies to provide long term and efficient protection, adoptive cell therapies now meet the demand for a large population of people who suffer immunocompromization, considering the previous usage of the technique for different infectious diseases.", 
    "doi": "10.55730/1300-0152.2579", 
    "has_grant": false, 
    "journal": {
      "issue": "2", 
      "pages": "105-117", 
      "title": "TURKISH JOURNAL OF BIOLOGY", 
      "volume": "46"
    }, 
    "license": {
      "id": "cc-by"
    }, 
    "publication_date": "2022-01-01", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "256005"
          }, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "256004"
          }
        }
      ]
    }, 
    "resource_type": {
      "subtype": "article", 
      "title": "Dergi makalesi", 
      "type": "publication"
    }, 
    "science_branches": [
      "Di\u011fer"
    ], 
    "title": "Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19"
  }, 
  "owners": [
    1
  ], 
  "revision": 1, 
  "stats": {
    "downloads": 10.0, 
    "unique_downloads": 10.0, 
    "unique_views": 35.0, 
    "version_downloads": 10.0, 
    "version_unique_downloads": 10.0, 
    "version_unique_views": 28.0, 
    "version_views": 32.0, 
    "version_volume": 2290.0, 
    "views": 42.0, 
    "volume": 2290.0
  }, 
  "updated": "2023-07-29T05:37:46.454760+00:00"
}
42
10
görüntülenme
indirilme
Görüntülenme 42
İndirme 10
Veri hacmi 2.3 kB
Tekil görüntülenme 35
Tekil indirme 10

Alıntı yap